Home/Pipeline/CFTR 100+ Panel

CFTR 100+ Panel

Cystic Fibrosis

CommercialActive

Key Facts

Indication

Cystic Fibrosis

Phase

Commercial

Status

Active

Company

Agena Bioscience

About Agena Bioscience

Agena Bioscience is a provider of targeted genomic analysis solutions, centered on its proprietary MassARRAY System which combines PCR with MALDI-TOF mass spectrometry. The company serves the research and clinical diagnostics markets with a focus on pharmacogenetics, oncology mutation profiling, hereditary genetics, and sample integrity testing. As a division of Mesa Labs, Agena operates globally with a business model based on selling instruments, consumable assays, and related services to molecular laboratories.

View full company profile

Therapeutic Areas

Oncology Genetic Disorders Pharmacogenomics

Other Cystic Fibrosis Drugs

Drug	Company	Phase	Status
CB-280	Calithera Biosciences	Preclinical/Phase 1	Discontinued
Ensifentrine	Verona Pharma	Phase 2	Under MSD
ALTA Drug Series	Alteron Therapeutics	Preclinical	Research
ColiFin®	Spexis	Marketed (EU)	Active
Cystic fibrosis (CRISPR)	GeneToBe	Discovery	Active
Cystic fibrosis (undisclosed)	GeneToBe	Early Discovery	Active
SM001 (alidornase/Tigerase)	SarcoMed USA	Research	Active
Targeted Lung Delivery	Nanite	Pre-clinical	Active
RIG-301 CFTR	RIGImmune	Pre-clinical	Active
CBN-101	Carbon Biosciences	Preclinical	Active
RESP® Biosensor Evaluation (with Rutgers Health)	Strados Labs	Research Study	Active
KIT2014	Kither Biotech	Phase 2	Active